UiPath Slides to 52-Week Low as AI Fears Mount
NEW YORK, May 1 —
UiPath (PATH) closed the week at $10.30, a fresh 52-week low for the automation software vendor and roughly 25% below the $13.81 average Wall Street price target. Retail investors are calling the selloff "irrational." The tape disagrees. Traders are betting that generative AI labs are about to eat the robotic process automation business alive.
- Stock at $10.30 vs. $13.81 analyst target, implying about 34% upside if the sell side is right
- $5.4B market cap on $1.61B trailing revenue growing 13.6%, with 83.2% gross margins
- $474M trailing free cash flow at an 11.5x forward P/E, with shares down roughly 33% year-to-date
The Anthropic Trade
The bear thesis fits in one line. If a frontier model can read a screen, click a button, and fill out a form, what is UiPath selling? Quiver Quantitative tied the recent weakness directly to "Anthropic Competition Fears" alongside the Q4 print. MSN ran the retail counter-narrative that the selloff is "irrational." The marginal seller doesn't agree.
The complication: RPA was never just about clicking buttons. It is about governance, audit trails, integration with legacy enterprise systems, and the unglamorous work of building automations that don't break when SAP pushes a patch. A general-purpose AI agent can mimic the demo. Whether it can survive a SOX audit is a different question, and one the market hasn't answered.
The Outlook Cut That Set the Tone
The damage didn't start this week. UiPath filed an 8-K on March 11 reporting Q4 results. TipRanks summed up the reaction in a headline: "UiPath Stock Sinks as Outlook Cut Shocks Investors." Two weeks later, on March 25, a second 8-K disclosed a departure or appointment of directors or principal officers under Item 5.02, paired with a Regulation FD disclosure.
An outlook cut followed by a board or officer change two weeks later is not a sequence the market shrugs off. Whether the personnel move was reactive or already in motion, the optics reinforced the bearish read.
What the Bears Are Missing
Strip away the AI panic and the financials don't look like a structurally impaired business. Revenue grew 13.6% on a trailing basis. Gross margin is 83.2% — software economics, not services economics. Trailing twelve-month free cash flow was $474 million. On a $5.4 billion market cap, that's an FCF yield north of 8%. The 11.5x forward P/E prices PATH closer to a mature industrial than a mid-cycle software company.
The earnings cadence backs up the cash flow. UiPath has beaten consensus EPS in each of its last four reported quarters: $0.11 against $0.10, $0.15 against $0.08, and $0.16 against $0.15. Those aren't blowouts. They aren't the misses you'd expect from a company being structurally displaced either. A business getting eaten by AI agents misses on revenue and guides down on margins. UiPath is doing neither — yet.
The Databricks Hedge
Then there's the late-April announcement that complicates the "RPA is obsolete" narrative. UiPath linked Databricks data with its AI workflows for real-time action, a deal covered by both Stock Titan and Quiver Quantitative. The logic is straightforward. If the future of automation is agentic AI operating on enterprise data, sitting inside the data plane where that data lives is a defensible place to be.
It's not a moat. It is evidence that management isn't waiting to be disrupted. The Databricks tie-up reads as a recognition that the next generation of automation will be model-driven, not script-driven, and that UiPath's enterprise distribution is worth more if it ships with AI baked in. The market, fixated on the Anthropic threat, has assigned this announcement roughly zero credit.
The Insider Footnote
A casual look at the Form 4 filings could mislead. On April 1, four senior officers — COO and CFO Ashim Gupta, General Counsel Brad Brubaker, CPO and CTO Raghavendra Malpani, and Chief Accounting Officer Hitesh Ramani — each received equity grants and disposed of shares at $11.10. Gupta picked up 306,748 shares and had 49,063 and 30,526 shares withheld for taxes. Brubaker received 157,208 with 24,842 and 30,442 withheld. Malpani took 159,125; Ramani 123,466. CEO and Chairman Daniel Dines filed three Form 4s on March 16, each tagged "Other" and each involving 9,615,297 shares.
The disposals look bigger than they are. Per the filings, the $544,599 and $338,839 sales by Gupta and the comparable lots from the other officers were tax-withholding on grant vesting, not discretionary selling. Open-market purchases over the last 90 days totaled zero. Open-market sales totaled zero. Insider activity here is mechanical compensation plumbing, not an information signal in either direction. Anyone reading the gross disposal numbers as a "vote of no confidence" is reading the wrong column of the spreadsheet.
What to Watch
The next checkpoint is UiPath's First Quarter Fiscal 2027 conference call, which the company has dated in a release. That print tests whether the cut outlook was a one-quarter reset or the start of a deceleration. Three numbers will tell the story:
First, net retention. If existing customers are pulling back on automation seats while they wait to see what Anthropic ships, it shows up here before it shows up in revenue. Second, AI-related bookings. Management needs to show that the Databricks integration and broader AI workflow push is translating into pipeline, not press releases. Third, free cash flow. The $474 million trailing figure is the load-bearing wall under the valuation. If FCF compresses, the 11.5x forward multiple loses its safety net.
The honest read is that this is two-sided. The bearish signals — the 52-week low, the outlook cut, persistent AI competition fears — are real. So are the bullish offsets: double-digit revenue growth at 83% gross margins, an 8%-plus FCF yield, four straight EPS beats, and a Databricks integration that suggests management sees what's coming. The market has picked its side. Whether that's prescient or premature is the bet.
Run the free UiPath, Inc. deep-dive →
Basis Report does not hold positions in securities discussed. This is not investment advice.
Frequently Asked Questions
Why is UiPath stock at a 52-week low?
Investors are pricing in competitive pressure from Anthropic and other AI labs, compounded by a cut outlook flagged after the March 11 Q4 release. The selling has pushed PATH to $10.30 against a $13.81 analyst target.
Did UiPath insiders sell stock recently?
Several officers including the CFO and General Counsel had shares withheld at $11.10 on April 1. Per the Form 4 filings, these were tax-withholding dispositions on vesting grants, not open-market sales. Open-market buying and selling over the last 90 days both totaled zero.
What is the UiPath Databricks partnership?
UiPath linked Databricks data with its AI workflows for real-time action in late April, per Stock Titan and Quiver Quantitative coverage. The article explains why the move matters given the Anthropic competition narrative.
Is UiPath profitable?
UiPath generated $474 million in trailing twelve-month free cash flow on $1.61 billion in revenue, and has beaten consensus EPS estimates in each of its last four reported quarters. The valuation context is covered above.
When does UiPath report next earnings?
UiPath has announced its First Quarter Fiscal 2027 conference call, per a release picked up by Stock Titan. The article outlines the three metrics that will determine whether the cut outlook was a one-time reset.